E-viri
Recenzirano
Odprti dostop
-
Aschner, Pablo; Sethi, Bipin; Gomez-Peralta, Fernando; Landgraf, Wolfgang; Loizeau, Virginie; Dain, Marie-Paule; Pilorget, Valerie; Comlekci, Abdurrahman
Journal of diabetes and its complications, 08/2015, Letnik: 29, Številka: 6Journal Article
Abstract Aims Demonstrate superiority of insulin glargine (± glulisine) strategy versus premixed insulin strategy for percentage of patients reaching HbA1c < 7% (< 53 mmol/mol) at study end without any documented symptomatic hypoglycemia (bloof glucose BG ≤ 3.1 mmol/L) in type 2 diabetes (T2DM) patients failing oral agents. Methods This 24-week, open-label, multinational trial randomized patients to glargine OD or premix OD or BID, continuing metformin ± insulin secretagogue (IS). Second premix injection could be added any time; glulisine could be added with main meal in glargine OD patients with HbA1c ≥ 7% and fasting blood glucose (FBG) < 7 mmol/L at week 12. IS was stopped with any second injection. Insulin titration targeted FBG ≤ 5.6 mmol/L. Results Modified intent-to-treat population comprised 923 patients (glargine, 462; premix, 461). Baseline characteristics were similar (mean T2DM duration: 9 years; HbA1c: 8.7% (72 mmol/mol); FBG: 10.4 mmol/L). Primary endpoint was achieved by 33.2% of glargine (± glulisine) and 31.4% of premix patients. Superiority was not demonstrated, but non-inferiority was (pre-specified margin: 25% of premix rate). More patients using premix achieved target (52.6% vs. 43.2%, p = 0.005); symptomatic hypoglycemia was less with glargine (1.17 vs. 2.93 events/patient–year). Conclusions Glargine (± glulisine) and premix strategies resulted in similar percentages of well-controlled patients without hypoglycemia, with more patients achieving target HbA1c with premix whereas overall symptomatic hypoglycemia was less with glargine.
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|
Vir: Osebne bibliografije
in: SICRIS
To gradivo vam je dostopno v celotnem besedilu. Če kljub temu želite naročiti gradivo, kliknite gumb Nadaljuj.